Cargando…

Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients

BACKGROUND: It is not fully explained why some active tuberculosis patients show negative interferon-γ release assays (IGRAs). In this study, we tried to explore associations of IGRAs with the characteristics of peripheral Vγ2Vδ2 T cells and their functions of producing cytokines. METHODS: 32 pulmon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Liping, Shen, Hongbo, Xiao, Heping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123966/ https://www.ncbi.nlm.nih.gov/pubmed/30180814 http://dx.doi.org/10.1186/s12879-018-3328-x

Ejemplares similares

Whole Blood Interferon-γ Release Assay Is Insufficient for the Diagnosis of Sputum Smear Negative Pulmonary Tuberculosis
por: Park, HeeJin, et al.
Publicado: (2014)

Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection
por: Cimini, Eleonora, et al.
Publicado: (2012)

Analysis of Factors Lowering Sensitivity of Interferon-γ Release Assay for Tuberculosis
por: Hang, Nguyen Thi Le, et al.
Publicado: (2011)

Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)

Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis
por: Ai, Lu, et al.
Publicado: (2019)

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
por: Ridgley, Laura A., et al.
Publicado: (2023)

Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area
por: Kim, Jong Keun, et al.
Publicado: (2013)

Influencial factors of the performance of interferon-γ release assays in the diagnosis of childhood tuberculosis
por: Li, Tao, et al.
Publicado: (2014)

Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan
por: Nishimura, Tomoyasu, et al.
Publicado: (2018)

Tuberculin skin tests and interferon-γ release assays in the diagnosis of tuberculosis infection
por: Yan, Marie, et al.
Publicado: (2023)

Performance of an interferon-γ release assay-based test for cell-mediated immunity to SARS-CoV-2
por: Fonseca Brito, Luís, et al.
Publicado: (2023)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India
por: Little, Kristen M., et al.
Publicado: (2015)

Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet’s disease
por: Wu, Xiuhua, et al.
Publicado: (2019)

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
por: Lange, Christoph, et al.
Publicado: (2017)

Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children
por: Yun, Ki Wook, et al.
Publicado: (2016)

Combining interferon-γ release assays with lymphocyte enumeration for diagnosis of Mycobacterium tuberculosis infection
por: Lv, Dingfeng, et al.
Publicado: (2020)

Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
por: Parita, Soni, et al.
Publicado: (2017)

Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
por: Johnson, Síle A, et al.
Publicado: (2023)

Increased Expression of IL-10 in Peripheral Blood Mononuclear Cells Correlates with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients
por: Guo, Jidong, et al.
Publicado: (2021)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates
por: Shen, Ling, et al.
Publicado: (2019)

Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China
por: Ji, Lei, et al.
Publicado: (2017)

Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
por: Soriano-Sarabia, Natalia, et al.
Publicado: (2015)

Diagnostic Utility of Interferon-γ Release Assay in Tuberculous Lymphadenitis
por: Ye, Susu, et al.
Publicado: (2017)

Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis
por: Banfield, Sally, et al.
Publicado: (2012)

Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment
por: Park, I-Nae, et al.
Publicado: (2017)

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells
por: Gu, Siyi, et al.
Publicado: (2015)

Role of Vγ9vδ2 T lymphocytes in infectious diseases
por: Gay, Laetitia, et al.
Publicado: (2022)

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
por: Nguyen, Duc T., et al.
Publicado: (2018)

Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis
por: Yamasue, Mari, et al.
Publicado: (2020)

Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
por: Wang, Jann-Yuan, et al.
Publicado: (2007)

Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity
por: Accardo-Palumbo, Antonina, et al.
Publicado: (2010)

Comparison of T-Cell Interferon-γ Release Assays for Mycobacterium tuberculosis-Specific Antigens in Patients with Active and Latent Tuberculosis
por: Kobashi, Yoshihiro, et al.
Publicado: (2010)

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination
por: Saad Albichr, Imane, et al.
Publicado: (2023)

Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence
por: Xu, Weili, et al.
Publicado: (2018)

A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients
por: Thedrez, Aurélie, et al.
Publicado: (2013)

Combined Antigen-Specific Interferon-γ and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection
por: Chesov, Dumitru, et al.
Publicado: (2015)

Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis(1)
por: Shen, Hongbo, et al.
Publicado: (2022)

Serial testing with an interferon-γ release assay in German healthcare workers
por: Schablon, Anja, et al.
Publicado: (2010)

Serial testing with the interferon-γ release assay in Portuguese healthcare workers
por: Torres Costa, José, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kpitm518ig8o81jj1cceeht7c4